Quality of life in cancer patients-a comparison of inpatient, outpatient, and rehabilitation settings
Standard
Quality of life in cancer patients-a comparison of inpatient, outpatient, and rehabilitation settings. / Hinz, Andreas; Weis, Joachim; Faller, Hermann; Brähler, Elmar; Härter, Martin; Keller, Monika; Schulz, Holger; Wegscheider, Karl; Koch, Uwe; Geue, Kristina; Götze, Heide; Mehnert, Anja.
in: SUPPORT CARE CANCER, Jahrgang 26, Nr. 10, 10.2018, S. 3533-3541.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Quality of life in cancer patients-a comparison of inpatient, outpatient, and rehabilitation settings
AU - Hinz, Andreas
AU - Weis, Joachim
AU - Faller, Hermann
AU - Brähler, Elmar
AU - Härter, Martin
AU - Keller, Monika
AU - Schulz, Holger
AU - Wegscheider, Karl
AU - Koch, Uwe
AU - Geue, Kristina
AU - Götze, Heide
AU - Mehnert, Anja
PY - 2018/10
Y1 - 2018/10
N2 - PURPOSE: The aim of this study was to compare quality of life (QoL) data from cancer patients in different clinical settings with data from the general population.METHODS: A sample of 4020 German cancer patients (1735 inpatients, 1324 outpatients, 961 participants in rehabilitation treatment) was tested with the EORTC QLQ-C30.RESULTS: Compared with the general population, cancer patients reported markedly worse QoL. There were clinically significant differences on all 15 scales of the EORTC QLQ-C30 (except one). For the sum score, averaging across 13 scales, the effect size of the difference between cancer patients and the general population was d = 1.16. Inpatients reported the greatest detriments to QoL, followed by the rehabilitation patients and the outpatients (mean sum scores 68.6, 71.0, and 72.3, respectively, compared with 89.2 in the general population). Mean scores for different groups of cancer sites are given separately for the three settings.CONCLUSION: The detriments to QoL were stronger than in comparable studies conducted on data from clinical trials. Since these detriments were found in all three settings to a similar degree, health care providers should offer their services not only to inpatients but to outpatients and patients treated in rehabilitation clinics as well. The data can be used for QoL comparisons of assessments from different settings.
AB - PURPOSE: The aim of this study was to compare quality of life (QoL) data from cancer patients in different clinical settings with data from the general population.METHODS: A sample of 4020 German cancer patients (1735 inpatients, 1324 outpatients, 961 participants in rehabilitation treatment) was tested with the EORTC QLQ-C30.RESULTS: Compared with the general population, cancer patients reported markedly worse QoL. There were clinically significant differences on all 15 scales of the EORTC QLQ-C30 (except one). For the sum score, averaging across 13 scales, the effect size of the difference between cancer patients and the general population was d = 1.16. Inpatients reported the greatest detriments to QoL, followed by the rehabilitation patients and the outpatients (mean sum scores 68.6, 71.0, and 72.3, respectively, compared with 89.2 in the general population). Mean scores for different groups of cancer sites are given separately for the three settings.CONCLUSION: The detriments to QoL were stronger than in comparable studies conducted on data from clinical trials. Since these detriments were found in all three settings to a similar degree, health care providers should offer their services not only to inpatients but to outpatients and patients treated in rehabilitation clinics as well. The data can be used for QoL comparisons of assessments from different settings.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Female
KW - Germany
KW - Humans
KW - Inpatients
KW - Male
KW - Middle Aged
KW - Neoplasms
KW - Outpatients
KW - Quality of Life
KW - Rehabilitation Centers
KW - Surveys and Questionnaires
KW - Journal Article
U2 - 10.1007/s00520-018-4211-4
DO - 10.1007/s00520-018-4211-4
M3 - SCORING: Journal article
C2 - 29700655
VL - 26
SP - 3533
EP - 3541
JO - SUPPORT CARE CANCER
JF - SUPPORT CARE CANCER
SN - 0941-4355
IS - 10
ER -